Gane Defends UFC 334 Title As Harrison Submits NunesGane Defends UFC 334 Title As Harrison Submits Nunes
Kayla Harrison portrait
Photo: The White House via Wikimedia Commons, Public domain, cropped and resized
Advertisement
MMAMMA News

Gane Defends UFC 334 Title As Harrison Submits Nunes

MMA News Staff
MMA Editorial Team ·

Ciryl Gane defended his heavyweight title for the first time Saturday night, taking a decision over previously undefeated Josh Hokit in the UFC 334 main event at Madison Square Garden.

Gane kept moving throughout the five-round bout, landing damaging strikes while staying off the mat against Hokit's relentless pace, per BJPenn.com. Hokit controlled the tempo but lacked the finishing damage that might have swayed the judges. In the co-main event, Kayla Harrison retained her women's bantamweight belt with a fourth-round submission over Amanda Nunes, dominating with her grappling despite getting tagged by Nunes' striking early.

What's Next For Gane And Hokit

A rematch with Alexander Volkov appears to be the logical next step for Gane. Volkov lost a controversial decision to the Frenchman in 2024 and has since reeled off three straight wins. That title defense could land late in the first quarter or early in the second quarter of 2027. Hokit, meanwhile, shouldn't fall far down the rankings despite the setback. A fight with Johnny Walker, who has looked sharp since moving up to heavyweight, would keep the American in the top five and position him for another title run with one or two wins.

Harrison's future remains unclear after the Nunes victory. She could retire or, if she continues, face backup fighter Joselyne Edwards next. Nunes, who came out of retirement for the Harrison bout, is expected to hang up the gloves again after the submission loss, cementing her legacy as one of the greatest female fighters in the sport's history.


Reported via:

  • BJPenn — What’s next for the stars of UFC 334?
Advertisement
Advertisement

Get Ringside Updates

Fight announcements, results, and analysis delivered to your inbox. No spam. Unsubscribe anytime.

Send me:

Join the discussion

Loading the discussion…